Ranitidine and Hypervolaemia - a phase IV clinical study of FDA data

Summary:

Hypervolaemia is reported as a side effect among people who take Ranitidine (ranitidine), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Gabapentin, and have Oedema peripheral.

The phase IV clinical study analyzes which people have Hypervolaemia when taking Ranitidine. It is created by eHealthMe based on reports of 233,168 people who have side effects when taking Ranitidine from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Hypervolaemia?

Hypervolaemia (abnormally increased volume of blood) is found to be associated with 382 drugs and 227 conditions by eHealthMe. Check the latest studies of Hypervolaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

233,168 people reported to have side effects when taking Ranitidine.
Among them, 28 people (0.01%) have Hypervolaemia.

Among these 28 people:

How long have people been on Ranitidine when they have Hypervolaemia? *

What is the gender of people who have Hypervolaemia when taking Ranitidine? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Hypervolaemia when taking Ranitidine? *

What are other drugs people take besides Ranitidine? *

What are other side effects people have besides Hypervolaemia? *

Acute Kidney Failure: 11 people, 39.29%
Pneumonia: 9 people, 32.14%
Cellulitis (infection under the skin): 9 people, 32.14%
Dizziness: 7 people, 25.00%
Pulmonary Oedema (fluid accumulation in the lungs): 7 people, 25.00%
Dyspnea (difficult or laboured breathing): 7 people, 25.00%
Back Pain: 6 people, 21.43%
Blood Bilirubin Increased: 6 people, 21.43%
Chest Pain: 6 people, 21.43%
Chronic Kidney Disease: 6 people, 21.43%

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 5 people, 17.86%
Thrombosis (formation of a blood clot inside a blood vessel): 4 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 14.29%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 14.29%
High Blood Cholesterol: 4 people, 14.29%
Immunodeficiency Common Variable: 4 people, 14.29%
Blood Pressure Abnormal: 3 people, 10.71%
Stress And Anxiety: 3 people, 10.71%
Leukaemia (blood or bone marrow cancer): 2 people, 7.14%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and have Hypervolaemia?

- Check whether Hypervolaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine:

Ranitidine (234,475 reports)

Hypervolaemia treatments and more:

Hypervolaemia (3,872 reports)

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypervolaemia:

Hypervolaemia (382 drugs)

Browse all the conditions that are associated with Hypervolaemia:

Hypervolaemia (227 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine (the active ingredients of Ranitidine) and Ranitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.